Skinvisible (OTCMKTS:SKVI) Announces Earnings Results

Skinvisible (OTCMKTS:SKVIGet Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.05) EPS for the quarter, Zacks reports.

Skinvisible Price Performance

Shares of OTCMKTS SKVI remained flat at $0.24 during mid-day trading on Thursday. 1,000 shares of the stock traded hands, compared to its average volume of 120. The business has a 50-day moving average of $0.34 and a 200-day moving average of $0.35. The company has a market capitalization of $1.28 million, a P/E ratio of -1.19 and a beta of 1.81. Skinvisible has a 52-week low of $0.08 and a 52-week high of $0.90.

About Skinvisible

(Get Free Report)

Skinvisible, Inc, together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company's flagship product is Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products.

Featured Articles

Earnings History for Skinvisible (OTCMKTS:SKVI)

Receive News & Ratings for Skinvisible Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skinvisible and related companies with MarketBeat.com's FREE daily email newsletter.